Therapeutics: GFT2I repeat domain containing 1 (GTF2IRD1); transforming growth factor β receptor II (TGFβ-RII; TGFBR2)

Cancer

INDICATION: Breast cancer

Patient sample and mouse studies suggest inhibiting TGFβ-RII could

Read the full 112 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE